Atea Pharmaceuticals Inc. (AVIR)
NASDAQ: AVIR
· Real-Time Price · USD
3.50
0.01 (0.29%)
At close: Aug 15, 2025, 3:59 PM
3.50
0.14%
After-hours: Aug 15, 2025, 04:10 PM EDT
Atea Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -37.16M | -34.27M | -33.54M | -31.15M | -40.52M | -63.17M | -39.16M | -33.14M | -28.18M | -35.47M | -34.43M | -8.07M | -31.34M | -42.08M | 117.13M | -28.19M | 1.54M | 30.71M |
Depreciation & Amortization | 104K | 104K | 104K | 104K | 104K | 104K | 104K | 104K | 104K | 104K | 104K | 106K | 43K | 7K | 7K | 7K | 8K | 7K |
Stock-Based Compensation | 4.67M | 6.95M | 14.3M | 12.16M | 12.72M | 12.59M | 12.16M | 12.38M | 12.35M | 12.54M | 11.64M | 11.5M | 11.91M | 11.66M | 11.35M | 10.99M | 10.01M | 7.27M |
Other Working Capital | -616K | -4.54M | -7.21M | -1.87M | 4.19M | -2.78M | 5.56M | 10.95M | 41K | -2.08M | -1.81M | -5.04M | -10.01M | -27.74M | -186.26M | 28.31M | -41.63M | -58.56M |
Other Non-Cash Items | -1.32M | -1.74M | -2.71M | -2.6M | -3.02M | -3.49M | 4.16M | 33.14M | 28.18M | -3.09M | -3M | -15.23M | -16K | 16K | -247.84M | -485K | -2.7M | 3.56M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -8.51M | -37.46M | -31.88M | n/a | n/a | n/a | n/a | n/a | 247.84M | n/a | n/a | n/a |
Change in Working Capital | 841K | -1.61M | -8.54M | -1.56M | -11.48M | 14.1M | 9.41M | 7.38M | 3.3M | -3.94M | 4.14M | -22.32M | 214K | -28.62M | -203.91M | 39.8M | -28.9M | -54.83M |
Operating Cash Flow | -32.87M | -30.56M | -30.4M | -23.04M | -42.2M | -39.87M | -21.83M | -17.59M | -16.12M | -29.85M | -21.55M | -21.24M | -19.19M | -59.01M | -75.42M | 22.6M | -17.35M | -16.84M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.94M | -20K | -1.88M | -44K | -4K | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -100.73M | -122.64M | -58.48M | -228.24M | -7.26M | -167.2M | -47.23M | -205.29M | -153.22M | -156.63M | -58.4M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 116.02M | 208.25M | 55.1M | 106.23M | 131.95M | 224M | 75M | 146.78M | 199.78M | 181.11M | 91.89M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 46.56K | 24.48K | -1.94M | -486.95M | n/a | n/a | -4K | n/a | n/a | n/a |
Investing Cash Flow | 15.29M | 85.61M | -3.37M | -122.01M | 124.69M | 56.8M | 27.77M | -58.51M | 46.56M | 24.48M | 33.49M | -486.98M | -1.88M | -44K | -4K | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -14.09M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 138K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 165K | -230K | 147K | n/a | 223K | 142K | 795K | 57K | 471K |
Financial Cash Flow | -14.09M | -347K | n/a | 117K | n/a | 150K | n/a | 92K | n/a | 165K | n/a | 147K | n/a | 223K | 142K | 795K | 57K | 471K |
Net Cash Flow | -31.67M | 54.7M | -33.77M | -144.93M | 82.48M | 17.09M | 5.94M | -76.01M | 30.45M | -5.21M | 11.94M | -508.07M | -21.07M | -58.83M | -75.28M | 23.4M | -17.29M | -16.37M |
Free Cash Flow | -32.87M | -30.56M | -30.4M | -23.04M | -42.2M | -39.87M | -21.83M | -17.59M | -16.12M | -29.85M | -19.6M | -21.26M | -21.07M | -59.05M | -75.43M | 22.6M | -17.35M | -16.84M |